Product Information
MYCOPHENOLATE 200 MG/ML SUSP is a generic product labeled by Lannett Company Inc., priced at $0.9440 per ML under NDC 00527516082. Its NADAC has been published 231 times since Feb 23, 2022.
FDA first approved this application on Jul 29, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Mycophenolate Mofetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Lannett Company Inc.NDC
00527516082
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA214525FDA Approved
7/29/2021
TE Code
AB
On Market Since
7/29/2021
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 200 MG/ML SUSP has been published 231 times since Feb 23, 2022, and over the history we have for it it has declined 79.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9440 per ML |
|---|---|
| All-time high | $5.7124 (Jun 15, 2022) |
| All-time low | $0.9324 (Jun 17, 2026) |
| 52-week high | $1.5140 |
| 52-week low | $0.9324 |
| Median price | $1.8495 |
| Average price | $2.4043 |
| Largest weekly change | -41.1% (Sep 21, 2022) |
| Weeks tracked | 231 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 200 MG/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 200 MG/ML SUSP, manufactured by Lannett Company Inc., is $0.9440 per ML (NDC 00527516082), effective Aug 19, 2026.
How has the price of MYCOPHENOLATE 200 MG/ML SUSP changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has declined 79.8%. It has been tracked across 231 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 200 MG/ML SUSP?
Since Feb 23, 2022, the NADAC for MYCOPHENOLATE 200 MG/ML SUSP has ranged from a low of $0.9324 (Jun 17, 2026) to a high of $5.7124 (Jun 15, 2022), with a median of $1.8495 per ML.
Are there cheaper alternatives to MYCOPHENOLATE 200 MG/ML SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLATE 200 MG/ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLATE 200 MG/ML SUSP?
MYCOPHENOLATE 200 MG/ML SUSP (NDC 00527516082) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.